Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals, Molecular Devices

Serologicals Acquires Upstate and Will Issue Shares to Molecular Devices

Serologicals will acquire Upstate Group for $205 million in stock and cash, according to SEC documents filed this week.

As part of the acquisition, Serologicals will issue shares to Molecular Devices and other Upstate shareholders, the company said in its 8-K filing.

Molecular Devices in 2001 acquired approximately a 20 percent stake in Argonex, the parent company of Upstate Biotechnology, for $10 million in cash. As part of the deal, the companies announced a 10-year strategic partnership to provide new consumable reagent kits to the high-throughput screening market.

The transaction is subject to adjustment for amounts required to repay Upstate’s debts and expenses and Upstate’s working capital on the closing of the deal.

Atlanta-based Serologicals said that it will issue up to 5 million shares its common stock, which closed at $23.23 Tuesday, and the balance of the price will be paid in cash.

Upstate sells cell signaling research reagents to academic, biotech, and pharmaceutical investigators. Serologicals expects the deal will provide the company with a significant presence in the preclinical drug screening and target validation market, with a focus on kinase screening and protein interaction. The firm also said that it expects the Upstate and Chemicon subsidiaries would launch approximately 1,500 new research products per year.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.